# Seer Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/seer-medical

- Industry: Healthcare
- Headquarters: Melbourne, Australia
- Website: www.seermedical.com
- Total disclosed funding: $26M
- Latest round: Series A (Aug 26, 2021)
- Investors on record: 5

## About

Seer Medical LLC, based in Australia, specializes in innovative home-based monitoring solutions for neurology, focusing on enhancing patient care through advanced video-EEG-ECG technology and data analytics.Seer Medical LLC provides home-based monitoring solutions for neurological conditions, allowing for comprehensive patient care. Founded in 2017 in Melbourne, Australia by Dean Freestone and George Kenley, the company has secured a Total Amount Raised of USD 39.25 mn in multiple funding rounds, with the latest round in April 2025 involving Breakthrough Victoria. Tim Nelson currently serves as the CEO.Seer Medical LLC offers a suite of home-based video-EEG-ECG monitoring solutions that enhance neurological patient care. Their flagship Seer Home service combines FDA-cleared medical devices, proprietary software, and consumables for effective patient monitoring in both clinical and home settings. The patented WaterTabs® electrode adhesive significantly improves data reliability and patient comfort during extended monitoring periods. Their products support various clinical needs, including seizure investigations and epilepsy treatment assessments, serving neurologists and epilepsy care specialists primarily in the United States and Australia.In 2022, Seer Medical LLC reported a revenue of USD 4,806,093.50 and an EBITDA of USD -14,684,423.90, operating on a subscription-based model that enables healthcare providers to utilize their monitoring solutions without upfront costs.In April 2025, Seer Medical LLC is poised to leverage recent funding from Cadwell Industries Inc. and SPRIM Global Investments to integrate its EEG technology with Cadwell's EEG portfolio. This funding aims to facilitate the development of new products and expand into additional markets, enhancing their capabilities and reach within the neurology sector.

## Funding rounds

- Series A, Aug 26, 2021, $24M — Cochlear Limited, SG Hiscock & Company, EWM Group, Giant Leap
- Series A, Feb 25, 2020, $2M — University of Melbourne Trusts Fund, Cochlear Limited, Giant Leap

## Investors

- University of Melbourne Trusts Fund — Series A
- Cochlear Limited — Series A
- Giant Leap (https://capitalatlas.ai/funds/giant-leap) — Series A
- SG Hiscock & Company — Series A
- EWM Group — Series A